Evidence map›Paper›PMID 32651653›Full record

ArticleArchives of toxicology2020

Autophagy alleviates amiodarone-induced hepatotoxicity.

Franziska Wandrer, Živa Frangež, Stephanie Liebig, Katharina John, Florian Vondran, Heiner Wedemeyer, Christian Veltmann, Tobias J Pfeffer, Oren Shibolet, Klaus Schulze-Osthoff and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Archives of toxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Hepatic cellular stress response pathways exhibit species differences in basal and inducible activity.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Acta pharmaceutica Sinica. B · 2022
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 4 countries.

Franziska WandrerDepartment of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany.
Živa FrangežInstitute of Pharmacology, University of Bern, Bern, Switzerland.
Stephanie LiebigDepartment of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany.
Katharina JohnDepartment of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany.
Florian VondranDepartment of Visceral and Transplantation Surgery, Hannover Medical School, Hannover, Germany.
Heiner WedemeyerDepartment of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany.
Christian VeltmannDepartment of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
Tobias J PfefferDepartment of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
Oren ShiboletDepartment of Gastroenterology and Hepatology, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Klaus Schulze-OsthoffInterfaculty Institute of Biochemistry, University of Tübingen, Tübingen, Germany.
Hans-Uwe SimonInstitute of Pharmacology, University of Bern, Bern, Switzerland.
Heike BantelDepartment of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany. Bantel.Heike@mh-hannover.de.ORCID 0000-0003-1443-2720
Medizinische Hochschule Hannover · DEUniversity of Bern · CHTel Aviv University · ILUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amiodarone is a widely used antiarrhythmic drug that can cause the development of steatohepatitis as well as liver fibrosis and cirrhosis. The molecular mechanisms of amiodarone-mediated liver injury remain largely unknown. We therefore analyzed amiodarone-mediated hepatocellular injury in patients with chronic heart failure, in primary hepatocytes and HepG2 cells. We found that amiodarone-treated patients with chronic heart failure revealed significantly higher serum levels of caspase-cleaved keratin-18, an apoptosis biomarker, compared to healthy individuals or patients not receiving amiodarone. Furthermore, amiodarone treatment of hepatocytes resulted in apoptosis associated with lipid accumulation and ER-stress induction. Liver cell steatosis was accompanied by enhanced de novo lipogenesis which, after reaching peak levels, declined together with decreased activation of ER stress. The decline of amiodarone-mediated lipotoxicity was associated with protective autophagy induction. In contrast, in hepatocytes treated with the autophagy inhibitor chloroquine as well as in autophagy gene (ATG5 or ATG7)-deficient hepatocytes, amiodarone-triggered toxicity was increased. In conclusion, we demonstrate that amiodarone induces lipid accumulation associated with ER stress and apoptosis in hepatocytes, which is mirrored by increased keratin-18 fragment serum levels in amiodarone-treated patients. Autophagy reduces amiodarone-mediated lipotoxicity and could provide a therapeutic strategy for protection from drug-induced liver injury.

Indexed as

AutophagyChemical and Drug Induced Liver InjuryAgedAmiodaroneAnti-Arrhythmia AgentsApoptosisCells, CulturedCell SurvivalChloroquineCRISPR-Cas SystemsEndoplasmic Reticulum StressFemaleGene Knockout TechniquesHepatocytesHep G2 CellsHumansAmiodaroneAnti-Arrhythmia AgentsChloroquineKeratin-18KRT18 protein, humanAmiodaroneApoptosisAutophagyDrug-induced liver injuryER stressKeratin-18

Identifiers

PMID32651653
PMCPMC7502042
OpenAlexW3040803013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.